Antibody treatment for infectious disease VS reccurence, how does it work?

Does anyone has any clue about how a treatment with monoclonal antibodies directed against a pathogen could lower the likelyhood of recurence of that infection? I guess it's through the activation of macrophage and NK cells through their Fc receptor, but what goes on downstream to build a memory for the next infection?
Thanks
Chris